Immunome, Inc.
IMNM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$57,457 | -$43,397 | -$41,640 | -$80,249 |
| Dep. & Amort. | $733 | $720 | $726 | $595 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $5,347 | $5,703 | $5,470 |
| Change in WC | $10,333 | -$11,757 | -$17,026 | $5,288 |
| Other Non-Cash | $5,881 | -$314 | -$818 | $26,836 |
| Operating Cash Flow | -$40,510 | -$49,401 | -$53,055 | -$42,060 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,116 | -$905 | -$3,665 | -$1,126 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$123,266 | $0 | -$73,867 |
| Inv. Sales/Matur. | $125,000 | $60,000 | $15,000 | $85,000 |
| Other Inv. Act. | $0 | $0 | -$6,246 | -$249 |
| Investing Cash Flow | $123,884 | -$64,171 | $5,089 | $9,758 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $45,389 | -$55 | $162,228 | $20,000 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $85 |
| Financing Cash Flow | $45,389 | -$55 | $162,228 | $20,085 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $128,763 | -$113,627 | $114,262 | -$12,217 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $143,876 | $257,713 | $143,351 | $155,668 |
| End Cash | $272,639 | $144,086 | $257,613 | $143,451 |
| Free Cash Flow | -$41,626 | -$50,306 | -$56,720 | -$43,435 |